STRO

SUTRO BIOPHARMA INC

STRO·869367201·US·Common Stock·Healthcare - Biotechnology-13D/G

STRO (SUTRO BIOPHARMA INC) is held by 43 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($17.9M), RA CAPITAL MANAGEMENT, L.P. ($17.8M), Point72 Asset Management, L.P. ($17.2M). Net institutional sentiment: Bullish.

43
Holders
Avg rating(7 Elite)
$132.1M
Total Value
73% (46)
Fund Consensus
30 buying - 11 selling
STROSmart Money Verdict
View all
Held by 43 funds
7 elite
Who's Trading
ActivistKYKynam Capital Management, LP5.3%May 15, 2026
ActivistAAAffinity Asset Advisors, LLC6.5%May 14, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.5.7%May 1, 2026
ActivistMillennium Management LLCMillennium Management LLC1.3%Apr 21, 2026
ActivistPAPerceptive Advisors LLC5.4%Apr 21, 2026
ActivistBVBIOTECHNOLOGY VALUE FUND L P4.1%Feb 18, 2026
InsiderCJChung JaneBuy $10KOct 15, 2025
InsiderGHGerber Hans-PeterBuy $14KOct 15, 2025
InsiderPDPauling DavidBuy $10KOct 15, 2025
InsiderMCMATSUI CONNIEBuy $40KOct 15, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
720,442$17.9M0.0%+50.91%
39
New
715,307$17.8M0.2%+50.91%
47
Increased
692,111(+286.5%)$17.2M0.0%+68.71%
46
Increased
465,792(+102.5%)$11.6M0.0%+88.95%
45
New
457,441$11.4M0.0%+50.91%
39
Increased
392,871(+4892.0%)$9.8M0.0%+52.62%
45
Increased
232,684(+98.1%)$5.8M0.0%+55.70%
44
Increased
222,634(+160.0%)$5.5M0.0%+99.11%
44
Decreased
210,378(-49.7%)$5.2M0.0%+160.48%
0
Unchanged
200,000$5M0.0%-20.65%
0
Increased
171,386(+104.1%)$4.3M0.0%-42.83%
43
Increased
117,537(+266.3%)$2.9M0.0%+69.81%
42
Decreased
97,824(-20.4%)$2.4M0.0%+20.34%
0
New
94,838$2.4M0.0%+50.91%
36
New
84,902$2.1M0.0%+50.91%
36
Increased
65,176(+40.2%)$1.6M0.0%+61.36%
34
Increased
52,118(+52.1%)$1.3M0.0%-8.34%
24
Decreased
35,295(-0.0%)$879,1980.0%-12.07%
0
New
34,343$855,4840.0%+50.91%
34
Increased
33,166(+130.7%)$826,1650.0%-49.18%
40

Showing 1-20 of 46

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used